Approval · Notice of Compliance 36200 · 2025
NITROJECT: Notice of Compliance 36200
Issued October 17, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36200
- Date
- October 17, 2025
- Company
- Juno Pharma Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Administrative: Merger/Buy-out. Administrative: Change in manufacturer name. Update to Product Monograph (to align with supporting PM). Update to package labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NITROJECT | 00778869 | Marketed |
Medicinal ingredients
- NITROGLYCERIN 50 MG per 10ML